Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
OmniAB Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OABI
Nasdaq
8731
https://www.omniab.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for OmniAB Inc
Insiders Load Up on These 2 Stocks — Here’s Why You Should Follow
- Apr 3rd, 2024 12:44 pm
OmniAb, Inc. (NASDAQ:OABI) Analysts Are More Bearish Than They Used To Be
- Mar 26th, 2024 10:11 am
OmniAb Inc (OABI) President and CEO Matthew Foehr Acquires 225,000 Shares
- Mar 25th, 2024 3:00 pm
OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript
- Mar 21st, 2024 3:31 pm
Q4 2023 OmniAb Inc Earnings Call
- Mar 21st, 2024 10:49 am
OmniAb Inc (OABI) Reports Decline in Annual Revenue and Net Loss for Q4 and Full Year 2023
- Mar 20th, 2024 9:52 pm
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
- Mar 20th, 2024 8:05 pm
OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?
- Feb 28th, 2024 1:27 pm
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
- Feb 26th, 2024 1:00 pm
OmniAb to Participate in Two Investor Conferences in March
- Feb 20th, 2024 1:00 pm
With 62% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns
- Jan 11th, 2024 11:16 am
Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
- Dec 15th, 2023 1:50 pm
President of OmniAb Matthew Foehr Buys 8.2% More Shares
- Dec 15th, 2023 10:10 am
OmniAb Inc CEO Matthew Foehr's Strategic 200,000 Share Acquisition
- Dec 15th, 2023 12:05 am
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
- Dec 14th, 2023 9:30 pm
Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 30%?
- Dec 5th, 2023 4:59 pm
OmniAb, Inc. (NASDAQ:OABI) Q3 2023 Earnings Call Transcript
- Nov 20th, 2023 5:39 pm
Matthew Foehr Bought 4.1% More Shares In OmniAb
- Nov 15th, 2023 10:06 am
Insider Buying: OmniAb Inc CEO Matthew Foehr Acquires 95,000 Shares
- Nov 14th, 2023 10:03 am
OmniAb, Inc. (NASDAQ:OABI) Analysts Just Slashed Next Year's Revenue Estimates By 14%
- Nov 14th, 2023 10:00 am
Scroll